| ASCENDIS PHARMA ADR |
| USA |
| Gesundheit |
| US04351P1012 / A14M6X |
| A71 (Frankfurt) / ASND (NASDAQ) |
| FRA:A71, ETR:A71, A71:GR, NASDAQ:ASND |
| - |
| https://ascendispharma.co.. |
|
Ascendis Pharma A/S is a biopharmaceutical company..
>Volltext.. |
| 10937.11 Mio. EUR |
| 11211.9 Mio. EUR |
| 613.86 Mio. EUR |
| -116.99 Mio. EUR |
| -218.03 Mio. EUR |
| -3.62 EUR |
| 814.33 Mio. EUR |
| 539.54 Mio. EUR |
| -100.24 Mio. EUR |
| 0.55 |
| 103.32% |
| 44.64% |
| - |
| - |
| - |
| - |
| ASCENDIS |
| 14.12.25 |
|